Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the previous funding-status notice (v3.4.1) as part of the site update. These updates do not alter the trial information or how users access it.
    Difference
    0.4%
    Check dated 2026-02-11T03:16:16.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The update introduces a site-wide funding notice and a new site version (v3.4.1), replacing the previous version (v3.4.0); these changes do not affect the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T02:00:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now includes a glossary display option and updated metadata: the additions are 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:28:10.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision changed from v3.3.3 to v3.3.4; no study content or data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:34:22.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Maryland location under a new Locations section and updated to revision v3.3.3; removed the Maryland Locations entry and the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T12:30:24.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2. No substantive changes to the study details are evident.
    Difference
    0.1%
    Check dated 2025-11-24T17:03:56.000Z thumbnail image

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.